PAO1 |
Wild-type strain used for mutational analysis in this and previous studies; originally isolated from a human wound in 1955 in Australia |
75 |
ΔprrF1,2 mutant |
Deletion mutant of entire prrF locus in PAO1 |
32 |
PAO1/pVLT31 |
Wild-type PAO1 strain carrying the pVLT31 broad-host-range vector (Tcr) |
33 |
ΔprrF1,2/pVLT31 mutant |
ΔprrF1,2 mutant carrying the pVLT31 broad-host-range vector (Tcr) |
33 |
ΔprrF1,2/pVLT-prrF1,2 mutant |
ΔprrF1,2 mutant carrying the prrF1,2 complementation construct (Tcr) |
32 |
PA14 |
Clinical isolate from 1995 at the Massachusetts General Hospital, Boston, MA; virulent in a variety of plant and animal models of infection |
56 |
FRD1 |
Mucoid clinical isolate in a sputum sample from a cystic fibrosis patient |
57 |
WR5 |
Clinical isolate from a burn patient at Walter Reed Army Hospital, Washington, DC, in 1976; natural toxA mutant isolate; virulent in exptl mouse models |
54, 55
|